inositol has been researched along with Hypothyroidism in 18 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Hypothyroidism: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The beneficial effects obtained by myo-inositol in association with seleno-methionine in patients affected by subclinical hypothyroidism have been recently demonstrated." | 9.24 | Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis. ( Antonelli, A; Benvenga, S; Di Bari, F; Fallahi, P; Ferrari, SM; Vita, R, 2017) |
| " Both metformin and myo-inositol were found to improve insulin sensitivity and to reduce thyrotropin levels in individuals with hypothyroidism." | 8.12 | Differences in levothyroxine action on thyroid autoimmunity and hypothalamic-pituitary-thyroid axis activity between metformin- and myo-inositol-treated women with autoimmune subclinical hypothyroidism. ( Kowalcze, K; Krysiak, R; Okopień, B, 2022) |
| "The present study aims to evaluate the effect of myo-Inositol plus Selenium supplementation in patients affected by subclinical hypothyroidism." | 8.12 | Supplementation with myo-inositol and Selenium improves the clinical conditions and biochemical features of women with or at risk for subclinical hypothyroidism. ( Džupon, M; Jackuliak, P; Kužma, M; Payer, J; Vaňuga, P, 2022) |
| "The effects of hypothyroidism on the muscarinic cholinergic receptor-coupled inositol phospholipid hydrolysis in the adult rat brain were examined." | 7.68 | Hypothyroidism inhibits the formation of inositol phosphate in response to carbachol in the striatum of adult rat. ( Iriuchijima, T; Michimata, T; Mizuma, H; Mori, M; Murakami, M; Yamada, M, 1991) |
| "Myoinositol (Myo) is an isoform of inositol, a cyclic polyol with 6 hydroxyl groups." | 6.82 | Myoinositol in Autoimmune Thyroiditis. ( Antonelli, A; Balestri, E; Benvenga, S; Botrini, C; Elia, G; Fallahi, P; Ferrari, SM; Guarneri, F; Paparo, SR; Patrizio, A; Ragusa, F, 2022) |
| "Myo-inositol (Myo-Ins) plays an important role in thyroid function and autoimmunity." | 6.58 | Myo-inositol in autoimmune thyroiditis, and hypothyroidism. ( Antonelli, A; Caruso, C; Elia, G; Fallahi, P; Ferrari, SM; Guglielmi, G; Paparo, SR; Ragusa, F, 2018) |
| "The beneficial effects obtained by myo-inositol in association with seleno-methionine in patients affected by subclinical hypothyroidism have been recently demonstrated." | 5.24 | Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis. ( Antonelli, A; Benvenga, S; Di Bari, F; Fallahi, P; Ferrari, SM; Vita, R, 2017) |
| " Both metformin and myo-inositol were found to improve insulin sensitivity and to reduce thyrotropin levels in individuals with hypothyroidism." | 4.12 | Differences in levothyroxine action on thyroid autoimmunity and hypothalamic-pituitary-thyroid axis activity between metformin- and myo-inositol-treated women with autoimmune subclinical hypothyroidism. ( Kowalcze, K; Krysiak, R; Okopień, B, 2022) |
| "The present study aims to evaluate the effect of myo-Inositol plus Selenium supplementation in patients affected by subclinical hypothyroidism." | 4.12 | Supplementation with myo-inositol and Selenium improves the clinical conditions and biochemical features of women with or at risk for subclinical hypothyroidism. ( Džupon, M; Jackuliak, P; Kužma, M; Payer, J; Vaňuga, P, 2022) |
| "The effects of hypothyroidism on the muscarinic cholinergic receptor-coupled inositol phospholipid hydrolysis in the adult rat brain were examined." | 3.68 | Hypothyroidism inhibits the formation of inositol phosphate in response to carbachol in the striatum of adult rat. ( Iriuchijima, T; Michimata, T; Mizuma, H; Mori, M; Murakami, M; Yamada, M, 1991) |
| " There was a decrease in sensitivity to isoproterenol in spontaneously beating right atria, electrically driven left atria and field-stimulated vas deferens associated with hypothyroidism, with no change in maximum response." | 3.67 | Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness. ( Abel, PW; Fox, AW; Johnson, RD; Juberg, EN; May, JM; Minneman, KP, 1985) |
| "Myoinositol (Myo) is an isoform of inositol, a cyclic polyol with 6 hydroxyl groups." | 2.82 | Myoinositol in Autoimmune Thyroiditis. ( Antonelli, A; Balestri, E; Benvenga, S; Botrini, C; Elia, G; Fallahi, P; Ferrari, SM; Guarneri, F; Paparo, SR; Patrizio, A; Ragusa, F, 2022) |
| "Myo-inositol (Myo-Ins) plays an important role in thyroid function and autoimmunity." | 2.58 | Myo-inositol in autoimmune thyroiditis, and hypothyroidism. ( Antonelli, A; Caruso, C; Elia, G; Fallahi, P; Ferrari, SM; Guglielmi, G; Paparo, SR; Ragusa, F, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Krysiak, R | 1 |
| Kowalcze, K | 1 |
| Okopień, B | 1 |
| Paparo, SR | 2 |
| Ferrari, SM | 3 |
| Patrizio, A | 1 |
| Elia, G | 2 |
| Ragusa, F | 2 |
| Botrini, C | 1 |
| Balestri, E | 1 |
| Guarneri, F | 1 |
| Benvenga, S | 3 |
| Antonelli, A | 3 |
| Fallahi, P | 3 |
| Payer, J | 3 |
| Jackuliak, P | 3 |
| Kužma, M | 3 |
| Džupon, M | 3 |
| Vaňuga, P | 3 |
| Di Bari, F | 1 |
| Vita, R | 1 |
| Nordio, M | 2 |
| Basciani, S | 2 |
| Caruso, C | 1 |
| Guglielmi, G | 1 |
| Morgante, G | 1 |
| Musacchio, MC | 1 |
| Orvieto, R | 1 |
| Massaro, MG | 1 |
| De Leo, V | 1 |
| Singh, S | 1 |
| Rana, P | 1 |
| Kumar, P | 1 |
| Shankar, LR | 1 |
| Khushu, S | 1 |
| Sijens, PE | 1 |
| Rödiger, LA | 1 |
| Meiners, LC | 1 |
| Lunsing, RJ | 1 |
| Gupta, RK | 1 |
| Bhatia, V | 1 |
| Poptani, H | 1 |
| Gujral, RB | 1 |
| Pintor, A | 1 |
| Fortuna, S | 1 |
| Lorenzini, P | 1 |
| Pascale, A | 1 |
| Battaini, F | 1 |
| Avellino, C | 1 |
| Malvezzi Campeggi, L | 1 |
| Salvati, S | 1 |
| Iriuchijima, T | 2 |
| Mizuma, H | 2 |
| Michimata, T | 2 |
| Ogiwara, T | 1 |
| Yamada, M | 2 |
| Murakami, M | 2 |
| Mori, M | 2 |
| Fox, AW | 1 |
| Juberg, EN | 1 |
| May, JM | 1 |
| Johnson, RD | 1 |
| Abel, PW | 1 |
| Minneman, KP | 1 |
| de Siebenthal, J | 1 |
| Jenny, M | 1 |
| Ishii, J | 1 |
| Nakao, K | 1 |
2 reviews available for inositol and Hypothyroidism
| Article | Year |
|---|---|
Myoinositol in Autoimmune Thyroiditis.
Topics: Hashimoto Disease; Humans; Hydrogen Peroxide; Hypothyroidism; Inositol; Thyroiditis, Autoimmune; Thy | 2022 |
Myo-inositol in autoimmune thyroiditis, and hypothyroidism.
Topics: Animals; Chemokine CXCL10; Humans; Hypothyroidism; Inositol; Thyroiditis, Autoimmune; Thyrotropin | 2018 |
2 trials available for inositol and Hypothyroidism
| Article | Year |
|---|---|
Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis.
Topics: Autoantibodies; Chemokine CXCL10; Disease Progression; Drug Therapy, Combination; Female; Humans; Hy | 2017 |
Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto's patients with subclinical hypothyroidism.
Topics: Adult; Autoantibodies; Autoantigens; Drug Therapy, Combination; Female; Hashimoto Disease; Humans; H | 2017 |
14 other studies available for inositol and Hypothyroidism
| Article | Year |
|---|---|
Differences in levothyroxine action on thyroid autoimmunity and hypothalamic-pituitary-thyroid axis activity between metformin- and myo-inositol-treated women with autoimmune subclinical hypothyroidism.
Topics: Autoimmunity; C-Reactive Protein; Female; Glucose; Hashimoto Disease; Humans; Hypothyroidism; Inosit | 2022 |
Supplementation with myo-inositol and Selenium improves the clinical conditions and biochemical features of women with or at risk for subclinical hypothyroidism.
Topics: Dietary Supplements; Female; Humans; Hypothyroidism; Inositol; Male; Selenium; Thyrotropin | 2022 |
Supplementation with myo-inositol and Selenium improves the clinical conditions and biochemical features of women with or at risk for subclinical hypothyroidism.
Topics: Dietary Supplements; Female; Humans; Hypothyroidism; Inositol; Male; Selenium; Thyrotropin | 2022 |
Supplementation with myo-inositol and Selenium improves the clinical conditions and biochemical features of women with or at risk for subclinical hypothyroidism.
Topics: Dietary Supplements; Female; Humans; Hypothyroidism; Inositol; Male; Selenium; Thyrotropin | 2022 |
Supplementation with myo-inositol and Selenium improves the clinical conditions and biochemical features of women with or at risk for subclinical hypothyroidism.
Topics: Dietary Supplements; Female; Humans; Hypothyroidism; Inositol; Male; Selenium; Thyrotropin | 2022 |
Evaluation of thyroid nodule characteristics in subclinical hypothyroid patients under a myo-inositol plus selenium treatment.
Topics: Adult; Antioxidants; Drug Therapy, Combination; Female; Humans; Hypothyroidism; Inositol; Male; Midd | 2018 |
Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.
Topics: Adult; Body Mass Index; Drug Therapy, Combination; Female; Hospitals, University; Humans; Hypoglycem | 2013 |
Hippocampal Neurometabolite Changes in Hypothyroidism: An In Vivo (1) H Magnetic Resonance Spectroscopy Study Before and After Thyroxine Treatment.
Topics: Adult; Female; Glutamic Acid; Hippocampus; Humans; Hypothyroidism; Inositol; Male; Proton Magnetic R | 2016 |
(Soft) capsules of wisdom: preventing myo-inositol malabsorption caused by coffee.
Topics: Biological Availability; Capsules; Coffee; Female; Gelatin; Gels; Humans; Hypothyroidism; Inositol; | 2012 |
1H magnetic resonance spectroscopy in monocarboxylate transporter 8 gene deficiency.
Topics: Aspartic Acid; Brain; Choline; Genotype; Humans; Hypothyroidism; Infant; Inositol; Magnetic Resonanc | 2008 |
Brain metabolite changes on in vivo proton magnetic resonance spectroscopy in children with congenital hypothyroidism.
Topics: Adolescent; Brain; Child; Choline; Congenital Hypothyroidism; Creatine; Humans; Hypothyroidism; Inos | 1995 |
Influences of hypothyroidism on lipid composition and inositol lipid-linked receptors responsiveness and protein kinase C (PKC) activity in the cerebral cortex of Lewis rats.
Topics: Animals; Carbachol; Cerebral Cortex; Cycloleucine; Hypothyroidism; Inositol; Inositol Phosphates; Ma | 1996 |
Thyroid hormone affects the hydrolysis of inositol phospholipids in the rat hypothalamus.
Topics: Animals; Chlorides; Hydrolysis; Hypothalamus; Hypothyroidism; In Vitro Techniques; Inositol; Inosito | 1992 |
Hypothyroidism inhibits the formation of inositol phosphate in response to carbachol in the striatum of adult rat.
Topics: Animals; Atropine; Binding Sites; Carbachol; Cell Membrane; Cerebral Cortex; Corpus Striatum; Hippoc | 1991 |
Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness.
Topics: Animals; Cerebral Cortex; Ethanolamines; Heart; Heart Rate; Hyperthyroidism; Hypothyroidism; In Vitr | 1985 |
[The hypercalcemias and their treatment].
Topics: Adrenal Cortex Hormones; Edetic Acid; Female; Humans; Hypercalcemia; Hyperthyroidism; Hypothyroidism | 1967 |
Analysis of the human erythrocyte lipid in various functional conditions of the thyroid.
Topics: Centrifugation; Cerebrosides; Cholesterol; Chromatography, Thin Layer; Densitometry; Erythrocytes; H | 1968 |